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1. Introduction 
Commercial preparations of the bile pigment, 
bilirubin, are used (frequently without further purifr- 
cation) in metabolic investigations, as a convenient 
starting material for the preparation of other bile pig 
ments, as standards for clinical analyses, and in studies 
of the chemistry of bilirubin itself. The commercial 
material, which is obtained from bile or gallstones of 
bovine or porcine origin, is generally believed to con- 
sist essentially of bilirubin IX-a (fig. 1 B) formed 
metabolically via stereospecific leavage of the 
a-methene bridge of protohaem-IX and the only 
isomer of bilirubin known to occur naturally. Although 
evidence has been published [l] suggesting that com- 
mercial bilirubin contains trace amounts of other 
isomers (bilirubin IX-0 and -6) arising from cleavage 
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Fig. 1. Structures of bilirubin III-a (A), IX-a (B) and XIII- 
a (0 
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of photohaem at the /I- and 6-methene bridge positions, 
more recent work [2] has shown these additional 
isomers comprise less than 0.5% of bilirubin isolated 
from bile. The latter observation, coupled with results 
from earlier studies using oxidative degradation 
techniques [3], forms the basis for the notion that 
bilirubin derived from natural sources has an isomeric 
purity (IX*) of > 99%. 
We have found that bilirubin from a number of 
commercial sources is separable by thin layer chro- 
matography (TLC) into three components, and present 
here unequivocal evidence that these are bilirubin 
IIIiv (A), bilirubin IX-a (B), and bilirubin XIII-a (C), 
isomeric bilirubins [4] with the structures shown in 
fig. 1. 
2. Materials and methods 
TLC plates (20 X 20 cm) were prepared using silica 
gel H (E. Merck). Plates were activated (60 min at 
120’), cooled to room temperature in air, and stored 
over silica gel dessicant in a closed chamber; plates were 
generally used within 2-24 hr after activation. Bili- 
rubin was applied as a filtered solution in CHCl, 
(1 mg/ml). Plates were developed (l-2 hr) in closed 
tanks containing 100 ml developing solvent and lined 
internally with filter paper saturated with solvent. 
For analytical work layers were 0.25 mm thick 
(solvent, 1% glacial CHsCO0I-I in ARCHCl,). For 
preparative work layers 0.5 mm thick were used; plates 
were activated, washed with methanol overnight by 
continous development, dried, and reactivated as above. 
Bilirubin solution (up to 400 pi/plate) was applied as 
a streak using a Cordis Microapplicator and the plates 
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were developed with 2% glacial CH,COOH in AR- 
CHCl, . Separated products were eluted from the 
adsorbent with CHCl,. Eluates were washed (H,O, 
0.1 M NaHCO,), filtered and evaporated to dryness 
in flasks coated internally with “Siliclad” to preveni 
loss of bilirubin by adsorption to glass [5] . 
3. Results 
Of the several samples of bilirubin examined, that 
supplied by Pfanstiehl Laboratories, Inc., (emax = 
61,700 in CHCl,) contained the least bilirubin 1X-o 
(< 65%). On the other hand, this material provided 
the richest source of the III- and XIII- (Y isomers and 
was used as starting material for their isolation. 
On TLC Pfanstiehl bilirubin showed three major 
yellow components with close Rt values (fig. 2), in 
addition to minor amounts of other more polar im- 
purities which were not examined. Preparative TLC of 
this material (73 plates; on 16 of these resolution of 
the two lower components was unsatisfactory and 
only the top band was collected) followed by crystal- 
lization of the products from CHCl,-MeOH, gave 
bilirubin 111-o (A, top band, 6 mg; AT:‘3 455-458 
nm, emax 65,200), bilirubin 1X-o (B, middle band, 18 
mg; XgH$l3 453-455 nm, emax 62,600), and bilirubin 
X11-a (C, lower band, 4 mg; XsHsl3 449-453 nm, emax 
52,500). The products decomposed on heating with- 
out melting (234-275”) and were shown to be essen- 
tially homogenous by TLC (fig. 2). Three-fold crysal- 
lization (CHCl,-MeOH) of the starting material caused 
no evident improvement in its homogeneity. 
The products were shown to be isomers of mole- 
cular formula C,,H,,N,O, by high resolution mass 
spectrometry [A, B, and C, M+ (found) = 584.262 f 
0.002; M+ (talc.) = 584.2631. Their low resolution 
mass spectra were alike, and similar to spectra pre- 
viously recorded for bilirubin 1X-a [6,7]. In particular 
each spectrum showed an intense pair of dipyrryl- 
methene fragment ions at m/e 286 and 299 arising 
from cleavage about the central methylene bridge. 
Chromic acid oxidation [8] of A, B, and C yielded 
methylvinylmaleimide in yields of 29,34, and 44% 
respectively but methylethylmaleimide was not 
detected, demonstrating the absence of ethyl side- 
chains and the presence in each compound of rings 
bearing both methyl and vinyl substituents. 
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Fig. 2. Thin layer chromatography of bilirubin. L. to r. Pfan- 
stiehl bilirubin, purified bilirubin X111-o (C), purified bilhubin 
IX-or (B), purified bilhubin III-ol (A), 3X crystallized Pfan- 
stiehl bilirubin. 
The absorption spectra of A, B,‘and C are qualita- 
tively similar, but the bathochromic and hyper- 
chromic trend from C to B to A was indicative of in- 
creasing conjugation in the same sequence. 
These observations suggested that A, B, and C are 
bilirubin III-, IX, and XIII-o, respectively. This con- 
clusion was proved by their conversion to the corre- 
sponding biliverdin dimethyl esters by oxidation with 
benzoquinone in DMSO-CHaCOOH followed by 
methylation [9]. Biliverdin 111-a dimethyl ester was 
obtained from A, biliverdin 1X-a dimethyl ester from 
B, and biliverdin X111-o dimethyl ester from C in 
respective yields of 36,44, and 43% (identification of 
the products was based on visible absorption spectra, 
melting points and TLC data). Oxidation of a concen- 
trated solution of B in DMSO-CH,COOH (4.4 mg/ml) 
yielded a mixture of bilirubin III-, IX-, and XIII-o 
due to acid-catalyzed isomerization of the starting 
material [9] . 
Because of its unsymmetrical substitution sequence, 
bilirubin 1X-a yields two isomeric azo-pigments on 
treatment with diazotized ethyl anthranilate and these 
are separable by TLC (silica gel; EtOAcCHCI, , 1: 1) 
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[lo] . In contrast, the symmetrically substituted III- 
and X111-a isomers hould each give a unique azo- 
pigment. Diazotization of B with ethyl anthranilate 
gave two azo-pigments; A gave one azo-pigment, 
having the same R, as the more polar of the pair 
obtained from B; and C also gave one azo-pigment, 
having the same Rt as the least polar of the pair from 
B. This result, besides confirming the structures of A, 
B, and C, enables tructures to be assigned absolutely 
to the isomeric azo-pigments isolated by Compernolle 
et al. [lo]. 
Under the conditions used for TLC, bilirubin 1X-o 
disproportionates to give trace amounts of the 111-o 
and X111-o isomers. This disproportionation is a com- 
plicating factor which must be recognized if TLC is 
used for analyses of bilirubin isomer mixtures. Pre- 
parative TLC experiments using purified bilirubin 
1X-a showed that the artifact& mixture of isomers 
thus formed contained 1% 111-o: 95% IX-a: 4% 
XIII-& 
Qualitative xamination of bilirubin samples 
from 15 different vendors by analytical TLC and 
quantitative analysis of 5 of these by preparative TLC 
indicated the presence of non-IX-a isomers in most of 
these samples in amounts ranging from trace quanti- 
ties to as much as 16% III-a: 62% 1X-o: 22% XIII-a 
for material from Pfanstiehl Laboratories. 
4. Discussion 
‘he discovery that commercial bilirubin may con- 
tain isomers other than IX-o, and in particular isomers 
which could not be directly derived from protohaem- 
IX, raises the question of their origin. Either they are 
artifacts of the commercial extraction processes and 
arise from acid or base-catalyzed isomerization of 
bilirubin IX-o, or they were naturally present in the 
original starting material. Both of these possibilities 
are currently under investigation. It should be noted 
that III-, IX-, and X111-a bile pigment isomers are not 
distinguishable by the oxidative degradation techniques 
[3, 111 which have been used as monitors of isomeric 
homogeneity in bile pigment research. 
Puzzling aspects of bilirubin chemistry have been 
the discordant range of extinction coefficients which 
have been recorded for the “pure” pigment [121 and 
the consequent difficulty of obtaining the compound 
sufficiently pure for a clinical analytical standard 
[13,14] . The work reported here provides at least a 
partial explanation for the former, and suggests a 
method for accomplishing the latter. Other implica- 
tions of this work will be discussed elsewhere. 
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